Q2 2019 EPS Estimates for Vapotherm Inc Lowered by Analyst (VAPO)

Vapotherm Inc (NYSE:VAPO) – William Blair reduced their Q2 2019 earnings estimates for shares of Vapotherm in a research report issued to clients and investors on Wednesday, May 8th. William Blair analyst M. Kaczor now forecasts that the company will post earnings per share of ($0.82) for the quarter, down from their previous forecast of ($0.74). William Blair also issued estimates for Vapotherm’s Q3 2019 earnings at ($0.79) EPS, Q4 2019 earnings at ($0.77) EPS, FY2019 earnings at ($3.14) EPS, Q2 2020 earnings at ($0.81) EPS, Q3 2020 earnings at ($0.80) EPS, Q4 2020 earnings at ($0.77) EPS and FY2020 earnings at ($3.17) EPS.

Vapotherm (NYSE:VAPO) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.76) EPS for the quarter, topping analysts’ consensus estimates of ($0.79) by $0.03. The business had revenue of $12.30 million during the quarter, compared to analyst estimates of $11.90 million.

VAPO has been the topic of a number of other research reports. Zacks Investment Research raised Vapotherm from a “sell” rating to a “hold” rating in a research note on Saturday. Canaccord Genuity boosted their price objective on Vapotherm from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Wednesday, March 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $26.50.

Vapotherm stock opened at $17.50 on Monday. The company has a current ratio of 5.82, a quick ratio of 4.84 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $309.14 million and a price-to-earnings ratio of -1.27. Vapotherm has a 52 week low of $14.70 and a 52 week high of $22.29.

Several institutional investors and hedge funds have recently modified their holdings of the company. Perceptive Advisors LLC acquired a new position in shares of Vapotherm during the fourth quarter valued at $24,464,000. Wells Fargo & Company MN lifted its stake in shares of Vapotherm by 15.4% during the first quarter. Wells Fargo & Company MN now owns 438,651 shares of the company’s stock valued at $8,619,000 after acquiring an additional 58,631 shares during the period. Federated Investors Inc. PA lifted its stake in shares of Vapotherm by 32.8% during the first quarter. Federated Investors Inc. PA now owns 398,435 shares of the company’s stock valued at $7,829,000 after acquiring an additional 98,435 shares during the period. Lord Abbett & CO. LLC acquired a new position in shares of Vapotherm during the fourth quarter valued at $7,573,000. Finally, BlackRock Inc. acquired a new position in shares of Vapotherm during the fourth quarter valued at $6,248,000. 45.91% of the stock is currently owned by institutional investors and hedge funds.

About Vapotherm

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Further Reading: Why do company’s buyback their stock?

Earnings History and Estimates for Vapotherm (NYSE:VAPO)

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.